[HTML][HTML] Fluoroquinolones hybrid molecules as promising antibacterial agents in the fight against antibacterial resistance
The emergence of bacterial resistance has motivated researchers to discover new
antibacterial agents. Nowadays, fluoroquinolones keep their status as one of the essential …
antibacterial agents. Nowadays, fluoroquinolones keep their status as one of the essential …
[HTML][HTML] MRGPRX2 and adverse drug reactions
BD McNeil - Frontiers in immunology, 2021 - frontiersin.org
Many adverse reactions to therapeutic drugs appear to be allergic in nature, and are thought
to be triggered by patient-specific Immunoglobulin E (IgE) antibodies that recognize the drug …
to be triggered by patient-specific Immunoglobulin E (IgE) antibodies that recognize the drug …
Importance of relating efficacy measures to unbound drug concentrations for anti-infective agents
D Gonzalez, S Schmidt… - Clinical microbiology …, 2013 - Am Soc Microbiol
For the optimization of dosing regimens of anti-infective agents, it is imperative to have a
good understanding of pharmacokinetics (PK) and pharmacodynamics (PD). Whenever …
good understanding of pharmacokinetics (PK) and pharmacodynamics (PD). Whenever …
Antimicrobial therapy for chronic bacterial prostatitis
G Perletti, E Marras… - Cochrane Database …, 2013 - cochranelibrary.com
Background Chronic bacterial prostatitis (CBP) is frequently diagnosed in men of fertile age,
and is characterized by a disabling array of symptoms, including pain in the pelvic area (for …
and is characterized by a disabling array of symptoms, including pain in the pelvic area (for …
Bacterial prostatitis
FME Wagenlehner, A Pilatz, T Bschleipfer… - World journal of …, 2013 - Springer
Objectives The prostatitis syndrome is classified into bacterial prostatitis (acute and chronic),
chronic pelvic pain syndrome and asymptomatic prostatitis. The aim of this report is to review …
chronic pelvic pain syndrome and asymptomatic prostatitis. The aim of this report is to review …
[HTML][HTML] Fluoroquinolone–macrolide combination therapy for chronic bacterial prostatitis: retrospective analysis of pathogen eradication rates, inflammatory findings …
We previously demonstrated the safety and efficacy of fluoroquinolone–macrolide
combination therapy in category II chronic bacterial prostatitis (CBP). The aim of this study is …
combination therapy in category II chronic bacterial prostatitis (CBP). The aim of this study is …
[HTML][HTML] Молекулярные и метаболические аспекты мужского бесплодия
ВН Павлов, ЭФ Галимова, БФ Терегулов… - Вестник …, 2016 - cyberleninka.ru
В обзоре на основе собственных и литературных данных рассмотрены молекулярные
и метаболические предпосылки развития идиопатического бесплодия у мужчин …
и метаболические предпосылки развития идиопатического бесплодия у мужчин …
Insight view on possible role of fluoroquinolones in cancer therapy
Cancer is a disease without limits turning out to be prime cause for raising death toll around
the world. Several treatment strategies including chemotherapy, surgery and radiotherapy …
the world. Several treatment strategies including chemotherapy, surgery and radiotherapy …
Population pharmacokinetic modeling of the unbound levofloxacin concentrations in rat plasma and prostate tissue measured by microdialysis
Levofloxacin is a broad-spectrum fluoroquinolone used in the treatment of both acute and
chronic bacterial prostatitis. Currently, the treatment of bacterial prostatitis is still difficult …
chronic bacterial prostatitis. Currently, the treatment of bacterial prostatitis is still difficult …
Macrolides for the treatment of chronic bacterial prostatitis: an effective application of their unique pharmacokinetic and pharmacodynamic profile
Chronic bacterial prostatitis (CBP) is a persistent infection of the prostate characterized by
poor quality of life mainly due to frequent relapse episodes caused by incomplete …
poor quality of life mainly due to frequent relapse episodes caused by incomplete …